Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Natural Resources
CNQ
|
+$1.33B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$985M |
| 3 |
Eli Lilly
LLY
|
+$901M |
| 4 |
Toronto Dominion Bank
TD
|
+$796M |
| 5 |
Blackrock
BLK
|
+$544M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$857M |
| 2 |
NVIDIA
NVDA
|
+$803M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$676M |
| 4 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$671M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$611M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.21% |
| 2 | Technology | 15.76% |
| 3 | Industrials | 7.12% |
| 4 | Healthcare | 6.97% |
| 5 | Consumer Discretionary | 6.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4576
Luxfer Holdings
LXFR
$457M
| $209K | ﹤0.01% |
17,658
+13,865
| +366% | +$182K |
|
4577
Ultragenyx Pharmaceutical
RARE
$2.61B
| $209K | ﹤0.01% |
5,790
-63,952
| -92% | -$2.66M |
|
4578
PGIM US Large-Cap Buffer 12 ETF February
FEBP
$25.8M
| $209K | ﹤0.01% |
7,589
+6,698
| +752% | +$190K |
|
4579
Capital Bancorp
CBNK
$613M
| $208K | ﹤0.01% |
7,310
-366
| -5% | -$10.8K |
|
4580
CALL
US Global Jets ETF
JETS
$824M
| $208K | ﹤0.01% |
+10,000
| New | +$245K |
|
4581
Utah Medical Products
UTMD
$226M
| $208K | ﹤0.01% |
3,717
-1,838
| -33% | -$110K |
|
4582
Invesco CurrencyShares Japanese Yen Trust
FXY
$426M
| $207K | ﹤0.01% |
3,372
+2,888
| +597% | +$175K |
|
4583
Green Dot
GDOT
$771M
| $207K | ﹤0.01% |
24,503
+16,974
| +225% | +$144K |
|
4584
Nano X Imaging
NNOX
$74.1M
| $207K | ﹤0.01% |
41,630
+10,401
| +33% | +$72K |
|
4585
Intellia Therapeutics
NTLA
$1.67B
| $206K | ﹤0.01% |
28,946
-8,698
| -23% | -$87.9K |
|
|
ORC
4586
Orchid Island Capital
ORC
$1.32B
| $206K | ﹤0.01% |
27,439
+1,916
| +8% | +$15.7K |
|
4587
Richtech Robotics
RR
$402M
| $206K | ﹤0.01% |
104,000
+68,834
| +196% | +$169K |
|
4588
BJ's Restaurants
BJRI
$1.45B
| $205K | ﹤0.01% |
6,007
+1,189
| +25% | +$42.2K |
|
4589
Cannae Holdings
CNNE
$635M
| $205K | ﹤0.01% |
11,201
-4,714
| -30% | -$88.9K |
|
4590
Jakks Pacific
JAKK
$294M
| $205K | ﹤0.01% |
8,299
-4,455
| -35% | -$126K |
|
4591
Norwood Financial Corp
NWFL
$376M
| $205K | ﹤0.01% |
8,472
-388
| -4% | -$9.94K |
|
4592
SFL Corp
SFL
$1.64B
| $205K | ﹤0.01% |
24,997
-10,717
| -30% | -$103K |
|
4593
United States Lime & Minerals
USLM
$3.37B
| $205K | ﹤0.01% |
2,314
-31,717
| -93% | -$3.3M |
|
|
ITWO
4594
ProShares Russell 2000 High Income ETF
ITWO
$203M
| $205K | ﹤0.01% |
5,678
+5,178
| +1,036% | +$201K |
|
4595
iShares Emerging Markets Equity Factor ETF
EMGF
$1.91B
| $204K | ﹤0.01% |
4,361
+348
| +9% | +$16.2K |
|
4596
Franklin Covey
FC
$229M
| $204K | ﹤0.01% |
7,388
-37
| -0.5% | -$1.23K |
|
4597
Wolfspeed
WOLF
$1.65B
| $204K | ﹤0.01% |
66,796
+37,787
| +130% | +$221K |
|
|
DEA
4598
Easterly Government Properties
DEA
$1.17B
| $203K | ﹤0.01% |
7,673
-328
| -4% | -$9.02K |
|
|
FIVA
4599
Fidelity International Value Factor ETF
FIVA
$607M
| $203K | ﹤0.01% |
7,617
+3,424
| +82% | +$89.4K |
|
4600
MVB Financial
MVBF
$398M
| $203K | ﹤0.01% |
11,716
+2,483
| +27% | +$46.7K |
|
Similar funds
Royal Bank of Canada's Q1 2025 Portfolio in Review
As of Q1 2025, Royal Bank of Canada held 7,428 positions worth $479B, down 4.4% from $501B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q1 2025 filing shows 373 new, 3,020 increased, 3,038 reduced and 434 closed positions. Its largest new stake was Sandisk: 233,868 shares worth $11.1M. The largest sale was HCA Healthcare, an estimated $857M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q1 2025 buy was Sandisk: 233,868 shares worth $11.1M.
- Royal Bank of Canada added most to Canadian Natural Resources in Q1 2025, an estimated $1.33B increase.
- Royal Bank of Canada's biggest Q1 2025 reduction was HCA Healthcare, cutting an estimated $857M.
- Royal Bank of Canada fully exited Aspen Technology Inc in Q1 2025, selling an estimated $42.5M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $479B portfolio in Q1 2025.
- Royal Bank of Canada opened 373 new positions and closed 434 in Q1 2025.
- Royal Bank of Canada's portfolio value fell 4.4% quarter-over-quarter to $479B.
Based on Royal Bank of Canada's 13F filing for Q1 2025, filed 15 May 2025.